All In MedTech

Device Trial Radar · NCT02448342

Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients

Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study

Last checked: Nov 21, 2026Latest source record: Dec 29, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 380 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

380

Planned (sponsor's estimate)

Start

Sep 2015

Primary completion

Nov 30, 2017

Study completion Nov 30, 2017

Sponsor

Lead sponsor
Sensible Medical Innovations Ltd.Not on our public-company list
Sponsor type
Industry
First posted
May 19, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multi center, randomized controlled study, to determine if a significant decrease in the rate of heart failure re-hospitalizations occurs during a follow-up period when - ReDS guided treatment is used as an adjunct to standard of care.

Conditions

  • Heart Failure

Interventions

  • Remote Dielectric Sensing (ReDS) Wearable SystemDevice

    The ReDS device provides noninvasive measurement of lung fluid content. It comprises a wearable vest with embedded sensors and a bedside console, with touch-screen display. A measurement reading is provided within 90sec. Results are shared with the treating physician via a secured web portal.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The rate of recurrent events of HF readmissionsTime frame: Entire follow-up period (Expected average of 6.5 months)

Locations

41 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

40 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.